TuHURA Biosciences
(NASDAQ) HURA
TuHURA Biosciences Financials at a Glance
Market Cap
$179.93M
Revenue (TTM)
$0.00
Net Income (TTM)
$30.06M
EPS (TTM)
$-0.63
P/E Ratio
-4.49
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Price
$2.75
Volume
33,206
Open
$2.83
Price
$2.75
Volume
33,206
Open
$2.83
Previous Close
$2.75
Daily Range
$2.55 - $2.83
52-Week Range
$0.41 - $4.30
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Price
$2.75
Volume
33,206
Open
$2.83
Previous Close
$2.75
Daily Range
$2.55 - $2.83
52-Week Range
$0.41 - $4.30
HURA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout TuHURA Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
22
CEO
James A. Bianco, MD
Website
www.tuhurabio.comHeadquarters
Tampa, US
HURA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-169%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
-22.27%
Dividend Yield
0.00%
Payout Ratio
-0.04%
Stock Overview
Market Cap
$179.93M
Shares Outstanding
63.58M
Volume
33.21K
Short Interest
0.00%
Avg. Volume
1.92M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$31.80M
EBITDA
$29.36M
Operating Cash Flow
$27.63M
Capital Expenditure
$76.08K
Free Cash Flow
$27.71M
Cash & ST Invst.
$3.62M
Total Debt
$502.67K
TuHURA Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$179.93M
N/A
Market Cap/Employee
$9.47M
N/A
Employees
19
N/A
Net Income
$6.77M
-12.9%
EBITDA
$6.13M
-12.4%
Quarterly Fundamentals
Net Cash
$3.12M
-75.0%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
-100.0%
Long Term Debt
$303.63K
+611.1%
Short Term Debt
$199.04K
+24.5%
Return on Assets
-1.10%
N/A
Return on Invested Capital
-1.48%
N/A
Free Cash Flow
$14.46M
-451.6%
Operating Cash Flow
$14.40M
-454.1%